$AVIR Atea Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atea Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atea Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atea Pharmaceuticals, Inc. for free.

CIK Number: 0001593899
IRS Number: 460574869
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AVIR
Company Address: 125 SUMMER STREET 16TH FLOOR BOSTON 02110
Phone number: 857-204-8109

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Atea Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Corcoran AndreaSee Remarks633,0040shares bought: 133,004 / shares sold: 0 BUYFeb 01 20212 months ago
Foster WayneSee Remarks00Feb 01 20212 months ago
Hammond Janet MJChief Development Officer00Feb 01 20212 months ago
Horga Maria ArantxaChief Medical Officer00Feb 01 20212 months ago
Sommadossi Jean-PierrePresident, CEO, and Chairman00Feb 01 20212 months ago
Vavricka JohnChief Commercial Officer82,5080shares bought: 82,508 / shares sold: 0 BUYFeb 01 20212 months ago

View all Atea Pharmaceuticals, Inc. insiders.

Atea Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 01 2021AVIRAtea Pharmaceutica ...Sommadossi Jean-PierrePresident, CEO, and ...Option ExerciseA73.00640,00046,720,000640,000
Feb 01 2021AVIRAtea Pharmaceutica ...Hammond Janet MJChief Development O ...Option ExerciseA73.00160,05011,683,650160,050
Feb 01 2021AVIRAtea Pharmaceutica ...Corcoran AndreaSee RemarksOption ExerciseA73.00148,85010,866,050148,850
Feb 01 2021AVIRAtea Pharmaceutica ...Vavricka JohnChief Commercial Of ...Option ExerciseA73.00117,3008,562,900117,300
Feb 01 2021AVIRAtea Pharmaceutica ...Horga Maria ArantxaChief Medical Offic ...Option ExerciseA73.00145,50010,621,500145,500
Feb 01 2021AVIRAtea Pharmaceutica ...Foster WayneSee RemarksOption ExerciseA73.0071,7505,237,75071,750
Feb 01 2021AVIRAtea Pharmaceutica ...Corcoran AndreaSee RemarksOption ExerciseA73.00148,85010,866,050148,850
Feb 01 2021AVIRAtea Pharmaceutica ...Vavricka JohnChief Commercial Of ...Option ExerciseA73.00117,3008,562,900117,300
Feb 01 2021AVIRAtea Pharmaceutica ...Horga Maria ArantxaChief Medical Offic ...Option ExerciseA73.00145,50010,621,500145,500
Feb 01 2021AVIRAtea Pharmaceutica ...Foster WayneSee RemarksOption ExerciseA73.0071,7505,237,75071,750
Nov 05 2020AVIRAtea Pharmaceutica ...Cormorant Asset Management, LPOption ExerciseC0.00417,36000
Nov 05 2020AVIRAtea Pharmaceutica ...Cormorant Asset Management, LPOption ExerciseC0.00712,25000
Nov 05 2020AVIRAtea Pharmaceutica ...Cormorant Asset Management, LPOption ExerciseC0.002,631,58000
Nov 05 2020AVIRAtea Pharmaceutica ...Cormorant Asset Management, LPOption ExerciseC0.001,650,16500
Nov 05 2020AVIRAtea Pharmaceutica ...Cormorant Asset Management, LPOption ExerciseC0.001,000,00000

View all Atea Pharmaceuticals, Inc. insider transactions.